MedPath
HSA Approval

DBL CISPLATIN INJECTION 1 mg/ml

SIN00762P

DBL CISPLATIN INJECTION 1 mg/ml

DBL CISPLATIN INJECTION 1 mg/ml

May 4, 1988

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01XA01

cisplatin

Manufacturer Information

PFIZER PRIVATE LIMITED

HOSPIRA AUSTRALIA PTY LTD

Active Ingredients

CISPLATIN

1 mg/ml

Cisplatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL CISPLATIN INJECTION 1 mg/ml - HSA Approval | MedPath